Target Healthcare REIT (LON:THRL) Reaches New 1-Year High – What’s Next?

Target Healthcare REIT (LON:THRL – Get Free Report)’s share price hit a new 52-week high during trading on Thursday. The company traded as high as GBX 117 and last traded at GBX 113, with a volume of 94144 shares changing hands. The stock had previously closed at GBX 113.

Wall Street Analyst Weigh In

Separately, Jefferies Financial Group restated a “hold” rating and set a GBX 101 price objective on shares of Target Healthcare REIT in a report on Wednesday, August 5th. One analyst has rated the stock with a Hold rating, According to data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of GBX 101.

Get Our Latest Stock Analysis on THRL

Target Healthcare REIT Price Performance

The business’s fifty day moving average price is GBX 112.21 and its 200-day moving average price is GBX 107.92. The stock has a market capitalization of £700.87 million, a price-to-earnings ratio of 8.99, a PEG ratio of 1.48 and a beta of 0.71.

Target Healthcare REIT (LON:THRL – Get Free Report) last posted its earnings results on Wednesday, September 23rd. The company reported GBX 13.32 earnings per share for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. Equities research analysts predict that Target Healthcare REIT will post 6.2219101 earnings per share for the current fiscal year.

About Target Healthcare REIT

(Get Free Report)

Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.

Further Reading

Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.